Ozempic Cost Without Insurance in 2026: List Price, $25 Savings Card, and Cheapest Cash Paths

The short version

Ozempic's list price is about $1,000 a month in 2026, but almost nobody actually pays that. [1] With commercial insurance plus Novo Nordisk's savings card, eligible patients pay as little as $25 a month. [2] Without insurance, Novo's own self-pay price is $199 for the first two fills of the starter dose, then $349 a month for most doses and $499 for the 2 mg pen. [3] The catch that shapes every price: Ozempic is FDA-approved for type 2 diabetes, not weight loss. [4] Coverage and the best savings hinge on a diabetes diagnosis. If you want an on-label weight prescription, Wegovy and Zepbound are the paths, and they are priced separately. [5][6]

Why Ozempic being a diabetes drug changes what you pay

Ozempic is semaglutide approved by the FDA to improve blood sugar in adults with type 2 diabetes, and to reduce the risk of major cardiovascular events in adults who have both type 2 diabetes and established heart disease. [4] Weight loss is not an approved use. The same molecule at a higher dose is sold as Wegovy, which carries the weight-management approval.

This matters for cost in two ways. First, insurers are far more likely to cover Ozempic when it treats diabetes than when it is prescribed off-label for weight, and prior authorization usually asks for a diabetes diagnosis code. Second, the manufacturer savings card requires the prescription to be for Ozempic and, in the covered-benefit version, requires your plan to cover it. If you are taking Ozempic purely to lose weight without diabetes, expect more denials and fewer discounts than a patient using it on-label.

The list price: what "$1,000 a month" really means

The wholesale acquisition cost (WAC), the sticker price before any discounts, has run near $1,000 per month for a single Ozempic pen in 2026. [1] That is the number that shows up in headlines and on a pharmacy receipt when nothing is applied. Almost no patient pays the full WAC, because insurance, savings cards, or self-pay programs sit in between.

The direction is downward. Novo Nordisk has announced it will cut Ozempic's list price to $675 per month for all doses effective January 1, 2027, roughly a 35% reduction. [1] That does not directly lower your copay if you are insured, but it can shrink what you owe in a deductible phase or if you pay cash at the counter without another discount applied.

What you pay with commercial insurance

If you have commercial or private insurance that covers Ozempic, Novo Nordisk's savings card is the main lever. Eligible patients pay as little as $25 for a 1-, 2-, or 3-month prescription. [2] The card caps how much it will cover per fill: about $100 for a 1-month supply, $200 for a 2-month supply, and $300 for a 3-month supply, so if your plan's cost-share is very high the card may not erase all of it. [2]

Your actual copay depends on your plan's formulary tier and where you are in your deductible. Before the deductible is met, you can owe a large share of that $1,000 list price even with a good plan, which is exactly when the savings card helps most, up to its per-fill cap. To use it, you generally need commercial insurance, a valid Ozempic prescription, and a US address. [2]

What you pay without insurance

Novo Nordisk runs a direct self-pay program for people paying cash. The introductory price is $199 per month, but it is narrow: it applies only to the first two fills of therapy and only to the 0.25 mg and 0.5 mg starter doses. [3] After that, the standard self-pay price is $349 per month for most doses, and $499 per month for the 2 mg pen. [3]

These self-pay prices are available through NovoCare Pharmacy (home delivery or CVS pickup), tens of thousands of retail pharmacies, and select telehealth partners. [3] Compared with the roughly $1,000 WAC, self-pay through the manufacturer is usually the cheapest legitimate cash route for brand-name Ozempic. One honest limitation: the low prices are tied to a diabetes prescription for Ozempic, so a cash weight-loss buyer is really shopping the Wegovy or Zepbound self-pay programs instead.

Medicare and Medicaid: why the savings card is off-limits

If you have Medicare, Medicaid, TRICARE, the VA, or any other government-funded plan, you cannot use the Ozempic savings card. This is not Novo Nordisk being stingy; federal anti-kickback law bars manufacturer copay coupons for people in government drug programs. [2] The rule applies even if the card would have saved you money.

For Medicare Part D members, whether Ozempic is affordable comes down to your specific plan's formulary and tier. Many Part D plans do cover Ozempic for type 2 diabetes, and the 2025 Part D out-of-pocket cap (about $2,000 per year for covered drugs) limits total exposure once you reach it. Medicare does not cover drugs prescribed solely for weight loss, which is another reason the diabetes indication drives access. If a coupon is not an option, a cash discount card or the manufacturer self-pay price may still beat your plan's price in the deductible phase, so compare both.

Pharmacy discount cards and cash prices

Third-party discount cards (GoodRx, SingleCare, and similar) advertise cash prices on Ozempic, often somewhere in the high hundreds to around $1,000 per month depending on pharmacy and location. They are not insurance and cannot be combined with a manufacturer copay card, but they can undercut an uninsured retail price and, occasionally, a high insured copay.

In practice, run three quotes before you fill: the manufacturer self-pay price, your insurance copay with the Novo savings card, and the best discount-card cash price at nearby pharmacies. Pick the lowest for that fill; there is no rule that you must use the same method every month. Prices move, pharmacies differ, and the winning option can change when your dose steps up from 0.5 mg to 1 mg to 2 mg.

On-label weight paths cost differently: Wegovy and Zepbound

If your goal is weight loss rather than diabetes control, the on-label prescriptions are Wegovy (semaglutide) and Zepbound (tirzepatide), each FDA-approved for chronic weight management in adults who meet BMI criteria. [5][6] They have their own list prices and their own manufacturer self-pay and savings programs, separate from Ozempic.

Because these are the approved weight drugs, insurers evaluate them under weight-management coverage, which many employer plans still exclude. That is why some patients are quoted a high cash price for weight treatment even when their neighbor pays little for Ozempic for diabetes. If you are comparing total cost for weight loss, price Wegovy and Zepbound directly rather than assuming Ozempic's diabetes pricing will apply to you.

How to actually lower your Ozempic bill

Start by confirming the indication: if you have type 2 diabetes, make sure the prescription and prior authorization reflect that, because it unlocks the best coverage and the savings card. If you are commercially insured, enroll in the Novo Nordisk savings card and expect to pay as little as $25 per fill up to the per-fill cap. [2] If you are uninsured, use the manufacturer self-pay price ($199 intro, then $349 to $499). [3] If you are on Medicare or Medicaid, skip the coupon (you are not eligible) and compare your Part D copay against a cash discount-card price. [2]

Two more moves save real money: ask your prescriber about a 90-day supply, which can lower the per-month cost and reduce pharmacy trips, and reprice at every dose change, since the cheapest route can flip as you titrate up. Keep receipts and quotes; the list price is falling to $675 in January 2027, so what you pay this year is not fixed. [1]